Chemical and Pharmaceutical Bulletin
Online ISSN : 1347-5223
Print ISSN : 0009-2363
ISSN-L : 0009-2363
Regular Articles
Optimization of Imidazole 5-Lipoxygenase Inhibitors and Selection and Synthesis of a Development Candidate
Takashi Mano, Rodney W. Stevens, Kazuo Ando, Makoto Kawai, Kiyoshi Kawamura, Kazunari Nakao, Yoshiyuki Okumura, Takako Okumura, Minoru Sakakibara, Kimitaka Miyamoto, Tetsuya Tamura
Author information
JOURNAL FREE ACCESS

2005 Volume 53 Issue 8 Pages 965-973

Details
Abstract
Structural modification of imidazole 5-lipoxygenase (5-LO) inhibitors for optimizing inhibitory potency, pharmacokinetic behavior and toxicity (ocular) profile led to 4-{3-[4-(2-methyl-1H-imidazol-1-yl)phenylthio]}phenyl-3,4,5,6-tetrahydro-2H-pyran-4-carboxamide (6) with no observable ocular toxicity. The orally active and safe imidazole 5-LO inhibitor 6 was selected as a clinical candidate and advanced to clinical studies. An improved synthesis of 6 is also discussed.
Content from these authors
© 2005 The Pharmaceutical Society of Japan
Previous article Next article
feedback
Top